What is Filana Therapeutics, Inc. (FLNA) stock price today?

Filana Therapeutics, Inc. (FLNA) currently trades at $1.44 per share. The stock has a market capitalization of $77.78M and a P/E ratio of —x.

Is FLNA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Filana Therapeutics, Inc. has a Smart Value Score of 36/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

FLNA

Filana Therapeutics, Inc.

NASDAQ: FLNA · HEALTHCARE · BIOTECHNOLOGY

$1.44

-7.69% today

Updated 2026-04-29

Market cap

$77.78M

P/E ratio

—

P/S ratio

2.54x

EPS (TTM)

$-1.88

Dividend yield

—

52W range

$1 – $5

Volume

0.5M

Market cap

$77.78M

P/E ratio

—

P/S ratio

2.54x

EPS (TTM)

$-1.88

Dividend yield

—

52W range

$1 – $5

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

4.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$8.00

+455.56%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-10.25M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-76.25M	$-97.22M	$-24.34M	$-90.97M	$-12.54M
EPS	—	—	—	—	$-1.88
Free cash flow	$-80.23M	$-82.44M	$-117.03M	$-32.83M	$-10.25M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FLNA	$77.78M	36	4.3	3.0	4.7	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Filana Therapeutics, Inc. trades at $1.44. Our Smart Value Score of 36/100 indicates the stock is weak.

Frequently asked questions

What is Filana Therapeutics, Inc.'s stock price?

Filana Therapeutics, Inc. (FLNA) trades at $1.44.

Is Filana Therapeutics, Inc. overvalued?

Smart Value Score 36/100 (Grade D, Sell).

What is the price target of Filana Therapeutics, Inc. (FLNA)?

The analyst target price is $8.00, representing +455.6% upside from the current price of $1.44.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.54x

ROE-82.70%

Beta-0.68

50D MA$1.92

200D MA$2.47

Shares out0.05B

Float0.04B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

FLNA vs LLY →FLNA vs JNJ →FLNA vs ABBV →Stock screener →